LA JOLLA, CA—New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human ...

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu SHELTON, CT / ACCESS Newswire / February 19, 2025 / NanoViricides, Inc. (the ...

Jan. 2, 2025 — A new study uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is ... Study Traces Ebola's Route ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

A suspected Ebola exposure at a Manhattan urgent-care facility had two patients rushed to the hospital by emergency workers in hazmat suits Sunday – but the disease was ruled out. The patients ...

Northwestern University researchers have identified structural features in engineered cell receptors that correlate with ...

The non-descript, pill-shaped cell is why we understand fundamental life processes (think DNA replication and transcription).

Monath should know. In 2023, he received the prestigious Sabin Vaccine Institute Gold Medal for developing other innovative vaccines for Ebola Zaire, smallpox, Japanese encephalitis, and West Nile ...

Evo 2 now includes information from humans, plants, and other eukaryotic species to expand its capabilities in generative functional genomics.

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...

Two patients were taken to a New York hospital by hazmat-suited emergency personnel on Sunday due to suspected Ebola exposure at a Manhattan urgent care center, but the infection could be ...